NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183202&from=4 CLASS PERIOD: July 18, 202 ...

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman is notifying investors in Coupang, Inc. (NYSE: CPNG) that a second securities class action has been filed expanding the Class Period and seeks to represent investors who purchased Coupang securities between May 7, 2025 and December 16, 2025. The Lead Plaintiff Deadline remains February 17, 2026. The firm is investigating the propriety of Coupang's statements about its disclosure controls, cybersecurity protocols and c ...

Core Viewpoint - A securities class action lawsuit has been filed against CarMax, Inc. for allegedly misleading investors regarding the company's financial health and operational performance during the specified class period from June 20, 2025, to November 5, 2025 [1] Group 1: Allegations - The Complaint alleges that CarMax failed to disclose underperformance of its 2022 and 2023 vintage loans [2] - It is claimed that CarMax's loss reserves were inadequate to cover the underperforming loans [2] - The company reportedly had an oversupply of vehicles in early 2025, leading to significant depreciation of its inventory [2] - The sales boost in mid-2025 was primarily driven by customers purchasing used cars due to concerns over potential new-car tariffs [2] - The allegations suggest that CarMax materially overstated customer receivables, inventory values, and earnings, misleading investors about its business and growth prospects [2] Group 2: Stock Price Impact - The truth about CarMax's financial situation emerged through two corrective disclosures, the first being on September 25, 2025, when the company reported weak fiscal Q2 2026 results, leading to a 20.1% drop in stock price [3] - The second disclosure occurred on November 4, 2025, when CarMax announced the termination of CEO William Nash and warned of a sharp decline in used-car sales, resulting in an additional 24.3% decline in stock price [3]

Core Points - Stride, Inc. is facing a securities class action lawsuit for failing to disclose material information during the class period from October 22, 2024, to October 28, 2025 [1][3] - The lawsuit is pending in the United States District Court for the Eastern District of Virginia, and investors have until January 12, 2026, to file lead plaintiff applications [1][6] Company Issues - On September 14, 2025, Gallup-McKinley County Schools Board of Education filed a complaint against Stride, alleging fraud and deceptive trade practices, including inflating enrollment numbers by retaining "ghost students" [4] - Following this news, Stride's share price dropped by $18.60, or 11.7%, closing at $139.76 on September 15, 2025 [4] - On October 28, 2025, Stride disclosed that "poor customer experience" led to higher withdrawal rates and lower conversion rates, resulting in an estimated 10,000-15,000 fewer enrollments, which negatively impacted the company's outlook [5] - This announcement caused Stride's share price to plummet by $83.48, or over 54%, closing at $70.05 on October 29, 2025 [5]

Core Viewpoint - Rosen Law Firm is urging investors of Jasper Therapeutics, Inc. to contact them regarding a class action lawsuit due to allegations of misleading business operations [1][2]. Summary by Sections Allegations - The lawsuit claims that Jasper Therapeutics made false and misleading statements, including: - Lack of necessary controls and procedures for third-party manufacturers to comply with cGMP regulations [3]. - Increased risk of confounding results in ongoing studies, negatively impacting regulatory and commercial prospects of products like briquilimab [3]. - Potential for disruptive cost-reduction measures due to the aforementioned failures [3]. - Overstated business and financial prospects, as well as clinical and commercial prospects of briquilimab [3]. - Public statements made by defendants were materially false and misleading [3]. Class Action Participation - Investors may be eligible to participate in the class action against Jasper Therapeutics, with a deadline to file motions for lead plaintiff by November 18, 2025 [4]. - Investors do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [4]. Rosen Law Firm Background - Rosen Law Firm is recognized for its commitment to shareholder rights litigation, having recovered over $1 billion for shareholders since its inception [6].

Core Viewpoint - KBR, Inc. is facing a securities class action lawsuit for failing to disclose material information during the specified Class Period, which has resulted in significant stock price declines following negative news related to a joint venture with HomeSafe Alliance [3][4]. Summary by Sections Lawsuit Details - The lawsuit is titled Norrman v. KBR, Inc., et al., No. 25-cv-04464, and is pending in the United States District Court for the Southern District of Texas [5]. - Investors who purchased KBR securities between May 6, 2025, and June 19, 2025, have until November 18, 2025, to file lead plaintiff applications [1][2]. Stock Price Impact - On June 19, 2025, KBR's joint venture, HomeSafe, announced the termination of a significant contract with the U.S. Department of Defense, leading to a drop in KBR's stock price by $3.85, or 7.29%, closing at $48.93 on June 20, 2025 [4]. - The stock experienced further decline, falling an additional $1.30, or 2.65%, to close at $47.63 on June 23, 2025 [4]. Company Background - KBR, Inc. has a 72% economic interest in HomeSafe Alliance, which was awarded a contract in 2021 to improve the military move system [4]. - Kahn Swick & Foti, LLC (KSF) is a prominent law firm specializing in securities litigation, representing various investors seeking recoveries for losses due to corporate fraud [5].

Core Viewpoint - A class action lawsuit has been filed against Snap Inc. for alleged violations of securities laws, specifically related to misleading statements about the impact of Apple's privacy changes on its advertising business [1][4]. Group 1: Lawsuit Details - The lawsuit is based on claims that Snap made false and misleading statements regarding its advertising capabilities in light of Apple's device privacy changes [4]. - The class period for the lawsuit is defined as between July 22, 2020, and October 21, 2021 [2]. - Investors who suffered losses during this period are encouraged to participate in the lawsuit before the deadline of January 10, 2021 [2]. Group 2: Company Statements - Snap allegedly downplayed the risks posed by Apple's privacy changes and overstated its commitment to user privacy [4]. - The company's public statements are claimed to have been materially misleading, leading to investor damages when the truth was revealed [4]. Group 3: Legal Representation - The Schall Law Firm specializes in securities class action lawsuits and is representing investors globally [5]. - Investors can contact the firm for a free discussion of their rights [3].

Core Viewpoint - A securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. for failing to disclose material information during its October 2024 IPO, with a deadline for lead plaintiff applications set for October 13, 2025 [1][2][3]. Company Information - KinderCare Learning Companies, Inc. is facing allegations related to its IPO Registration Statement and Prospectus, claiming violations of federal securities laws [3]. - The lawsuit is identified as Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424 [5]. Allegations - The lawsuit alleges that KinderCare failed to disclose numerous incidents of child abuse, neglect, and harm at its facilities [4]. - It is claimed that the company did not provide the "highest quality care possible" and failed to meet basic standards in the child care industry, exposing it to undisclosed risks of lawsuits and reputational damage [4]. Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the plaintiffs in this case [6]. - The firm has been recognized among the top 10 firms nationally based on total settlement value, indicating its significant role in securities litigation [6].

Core Viewpoint - iRobot Corporation is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its restructuring plan and ability to operate as a standalone company after the termination of its acquisition by Amazon [1][2]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 29, 2024, to March 11, 2025 [1]. - Allegations include that iRobot overstated the effectiveness of its restructuring plan, leading to doubts about its ability to operate profitably as an independent entity [1]. - The lawsuit claims that there was substantial doubt about iRobot's ability to continue as a going concern, making the defendants' public statements materially false and misleading [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by September 5, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Rocket Companies, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical financial information during a specified class period [1][2]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from March 29, 2021, to April 1, 2021 [2]. - Allegations include that Rocket's gain on sale margins were contracting at the highest rate in two years due to increased competition among mortgage lenders and unfavorable shifts in operational segments [2]. - It is claimed that Rocket was engaged in a price war, further compressing margins in its Partner Network segment [2]. - The adverse trends were reportedly accelerating, with gain on sale margins expected to drop at least 140 basis points in the first half of 2021 [2]. - The favorable market conditions that previously allowed Rocket to achieve high gain on sale margins had disappeared, returning margins to levels not seen since Q1 2019 [2]. - Overall, the defendants' positive statements about the company's operations were deemed materially misleading [2]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 8, 2025, to participate in the case [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software [3]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [4]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that led to artificial inflation of stock prices [4].